Central and peripheral pulmonary sclerosing pneumocytomas: multi-phase CT study and comparison with Ki-67

1. Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer 1956; 9: 53–75. doi: 10.1002/1097-0142(195601/02)9:1<53::aid-cncr2820090104>3.0.co;2-u LiebowAA HubbellDS Sclerosing hemangioma (histiocytoma, xanthoma) of the lung Cancer 1956 9 53 75 10.1002/1097-0142(195601/02)9:1<53::aid-cncr2820090104>3.0.co;2-u Open DOISearch in Google Scholar

2. Jiang L, Huang Y, Tang Q, Zhao Q, Li Y, Wu X, et al. ¹⁸F-FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma. Oncol Lett 2018; 16: 660–5. doi: 10.3892/ol.2018.8660 JiangL HuangY TangQ ZhaoQ LiY WuX ¹⁸F-FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma Oncol Lett 2018 16 660 5 10.3892/ol.2018.8660 Open DOISearch in Google Scholar

3. Hung JH, Hsueh C, Liao CY, Ho SY, Huang YC. Pulmonary hilar tumor: an unusual presentation of sclerosing hemangioma. Case Rep Med 2016; 16: 1–6. doi: 10.1155/2016/8919012 HungJH HsuehC LiaoCY HoSY HuangYC Pulmonary hilar tumor: an unusual presentation of sclerosing hemangioma Case Rep Med 2016 16 1 6 10.1155/2016/8919012 Open DOISearch in Google Scholar

4. Lei Y, Yong D, Jun-Zhong R, Zhi Y, Zi-Tong W. Treatment of 28 patients with sclerosing hemangioma (SH) of the lung. J Cardiothorac Surg 2012; 7: 34. doi: 10.1186/1749-8090-7-34 LeiY YongD Jun-ZhongR ZhiY Zi-TongW Treatment of 28 patients with sclerosing hemangioma (SH) of the lung J Cardiothorac Surg 2012 7 34 10.1186/1749-8090-7-34 Open DOISearch in Google Scholar

5. Jungraithmayr W, Eggeling S, Ludwig C, Kayser G, Passlick B. Sclerosing hemangioma of the lung: a benign tumour with potential for malignancy? Ann Thorac Cardiovasc Surg 2006; 12: 352–4. PMID: 17095978 JungraithmayrW EggelingS LudwigC KayserG PasslickB Sclerosing hemangioma of the lung: a benign tumour with potential for malignancy? Ann Thorac Cardiovasc Surg 2006 12 352 4 17095978 Search in Google Scholar

6. Miyagawa-Hayashino A, Tazelaar HD, Langel DJ, Colby TV. Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases. Arch Pathol Lab Med 2003; 127: 321–5. doi: 10.5858/2003-127-0321-PSHWLN Miyagawa-HayashinoA TazelaarHD LangelDJ ColbyTV Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases Arch Pathol Lab Med 2003 127 321 5 10.5858/2003-127-0321-PSHWLN Open DOISearch in Google Scholar

7. Wei S, Tian J, Song X, Chen Y. Recurrence of pulmonary sclerosing hemangioma. Thorac Cardiovasc Surg 2008; 56: 120–2. doi: 10.1055/s-2007-989280 WeiS TianJ SongX ChenY Recurrence of pulmonary sclerosing hemangioma Thorac Cardiovasc Surg 2008 56 120 2 10.1055/s-2007-989280 Open DOISearch in Google Scholar

8. Yang CH, Lee LY. Pulmonary sclerosing pneumocytoma remains a diagnostic challenge using frozen sections: a clinicopathological analysis of 59 cases. Histopathology 2018; 72: 500–8. doi: 10.1111/his.13391 YangCH LeeLY Pulmonary sclerosing pneumocytoma remains a diagnostic challenge using frozen sections: a clinicopathological analysis of 59 cases Histopathology 2018 72 500 8 10.1111/his.13391 Open DOISearch in Google Scholar

9. Folescu R, Levai CM, Grigoraş ML, Arghirescu TS, Talpoş IC, Gîndac CM, et al. Expression and significance of Ki-67 in lung cancer. Rom J Morphol Embryol 2018; 59: 227–33. PMID: 29940632 FolescuR LevaiCM GrigoraşML ArghirescuTS TalpoşIC GîndacCM Expression and significance of Ki-67 in lung cancer Rom J Morphol Embryol 2018 59 227 33 29940632 Search in Google Scholar

10. Martin B, Paesmans M, Mascaux C, Berghmans T, Lothaire P, Meert AP, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer 2004; 91: 2018–25. doi: 10.1038/sj.bjc.6602233 MartinB PaesmansM MascauxC BerghmansT LothaireP MeertAP Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis Br J Cancer 2004 91 2018 25 10.1038/sj.bjc.6602233 Open DOISearch in Google Scholar

11. Jakobsen JN, Sørensen JB. Clinical impact of Ki-67 labeling index in non-small cell lung cancer. Lung Cancer 2013; 79: 1–7. doi: 10.1016/j.lung-can.2012.10.008 JakobsenJN SørensenJB Clinical impact of Ki-67 labeling index in non-small cell lung cancer Lung Cancer 2013 79 1 7 10.1016/j.lung-can.2012.10.008 Open DOISearch in Google Scholar

12. Lim JH, Lee N, Choi DW, Oh HJ, Park HY, Kim KH, et al. Pulmonary sclerosing pneumocytoma mimicking lung cancer: case report and review of the literature. Thorac Cancer 2016; 7: 508–11. doi: 10.1111/1759-7714.12341 LimJH LeeN ChoiDW OhHJ ParkHY KimKH Pulmonary sclerosing pneumocytoma mimicking lung cancer: case report and review of the literature Thorac Cancer 2016 7 508 11 10.1111/1759-7714.12341 Open DOISearch in Google Scholar

13. Zhu J. Analysis of the clinical differentiation of pulmonary sclerosing pneumocytoma and lung cancer. J Thorac Dis 2017; 9: 2974–81. doi: 10.21037/jtd.2017.08.07 ZhuJ Analysis of the clinical differentiation of pulmonary sclerosing pneumocytoma and lung cancer J Thorac Dis 2017 9 2974 81 10.21037/jtd.2017.08.07 Open DOISearch in Google Scholar

14. Lee E, Park CM, Kang KW, Goo JM, Kim MA, Paeng JC, et al. ¹⁸F-FDG PET/CT features of pulmonary sclerosing hemangioma. Acta Radiologica 2013; 54: 24–9. doi: 10.1258/ar.2011.110474 LeeE ParkCM KangKW GooJM KimMA PaengJC ¹⁸F-FDG PET/CT features of pulmonary sclerosing hemangioma Acta Radiologica 2013 54 24 9 10.1258/ar.2011.110474 Open DOISearch in Google Scholar

15. Nakatani Y, Inayama Y, Kamijo S, Ogawa N. Sclerosing lung hemagioma. Am J Surg Pathol 1999; 23: 240–1. doi: 10.1097/00000478-199902000-00019 NakataniY InayamaY KamijoS OgawaN Sclerosing lung hemagioma Am J Surg Pathol 1999 23 240 1 10.1097/00000478-199902000-00019 Open DOISearch in Google Scholar

16. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015; 10: 1243–60. doi: 10.1097/JTO.0000000000000630 TravisWD BrambillaE NicholsonAG YatabeY AustinJHM BeasleyMB The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification J Thorac Oncol 2015 10 1243 60 10.1097/JTO.0000000000000630 Open DOISearch in Google Scholar

17. Soo IX, Sittampalam K, Lim CH. Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis. Asian Cardiovasc Thorac Ann 2017; 25: 547–9. doi: 10.1177/0218492317727668 SooIX SittampalamK LimCH Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis Asian Cardiovasc Thorac Ann 2017 25 547 9 10.1177/0218492317727668 Open DOISearch in Google Scholar

18. Iyoda A, Hiroshima K, Shiba M, Haga Y, Moriya Y, Sekine Y, et al. Clinicopathological analysis of pulmonary sclerosing hemangioma. Ann Thorac Surg 2004; 78: 1928–31. doi: 10.1016/j.athoracsur.2004.05.069 IyodaA HiroshimaK ShibaM HagaY MoriyaY SekineY Clinicopathological analysis of pulmonary sclerosing hemangioma Ann Thorac Surg 2004 78 1928 31 10.1016/j.athoracsur.2004.05.069 Open DOISearch in Google Scholar

19. Sobecki M, Mrouj K, Colinge J, Gerbe F, Jay P, Krasinska L, et al. Cell-cycle regulation accounts for variability in Ki-67 expression levels. Cancer Res 2017; 77: 2722–34. doi: 10.1158/0008-5472.CAN-16-0707 SobeckiM MroujK ColingeJ GerbeF JayP KrasinskaL Cell-cycle regulation accounts for variability in Ki-67 expression levels Cancer Res 2017 77 2722 34 10.1158/0008-5472.CAN-16-0707 Open DOISearch in Google Scholar

20. Rivera E, Gesthalter Y, VanderLaan P, Parikh MS. Pulmonary sclerosing pneumocytoma. J Bronchology Interv Pulmonol 2018; 25: 54–6. doi: 10.1097/LBR.0000000000000508 RiveraE GesthalterY VanderLaanP ParikhMS Pulmonary sclerosing pneumocytoma J Bronchology Interv Pulmonol 2018 25 54 6 10.1097/LBR.0000000000000508 Open DOISearch in Google Scholar

21. Seigneurin D, Guillaud P. [Ki-67 antigen, a cell cycle and tumor growth marker]. [French]. Pathol Biol 1991; 39: 1020–8. PMID: 1666669 SeigneurinD GuillaudP [Ki-67 antigen, a cell cycle and tumor growth marker]. [French] Pathol Biol 1991 39 1020 8 1666669 Search in Google Scholar

22. Swensen SJ, Viggiano RW, Midthun DE, Müller NL, Sherrick A, Yamashita K, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214: 73–80. doi: 10.1148/radiology.214.1.r00ja1473 SwensenSJ ViggianoRW MidthunDE MüllerNL SherrickA YamashitaK Lung nodule enhancement at CT: multicenter study Radiology 2000 214 73 80 10.1148/radiology.214.1.r00ja1473 Open DOISearch in Google Scholar

23. Ganeshan B, Miles KA. Quantifying tumour heterogeneity with CT. Cancer Imaging 2013; 13: 140–9. doi: 10.1102/1470-7330.2013.0015 GaneshanB MilesKA Quantifying tumour heterogeneity with CT Cancer Imaging 2013 13 140 9 10.1102/1470-7330.2013.0015 Open DOISearch in Google Scholar

24. Yi CA, Lee KS, Kim EA, Han J, Kim H, Kwon OJ, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 2004; 233: 191–9. doi: 10.1148/radiol.2331031535 YiCA LeeKS KimEA HanJ KimH KwonOJ Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density Radiology 2004 233 191 9 10.1148/radiol.2331031535 Open DOISearch in Google Scholar

25. Neuman J, Rosioreanu A, Schuss A, Turi G, Yung E, Trow TK, et al. Radiology-pathology conference: sclerosing hemangioma of the lung. Clin Imaging 2006; 30: 409–12. doi: 10.1016/j.clinimag.2006.05.030 NeumanJ RosioreanuA SchussA TuriG YungE TrowTK Radiology-pathology conference: sclerosing hemangioma of the lung Clin Imaging 2006 30 409 12 10.1016/j.clinimag.2006.05.030 Open DOISearch in Google Scholar

26. Xu G, Wang Z, Xiong Z, Li M, Luo W, Xu Y, et al. Correlation between pulmonary sclerosing pneumocytoma features and MSCT imaging manifestations in 34 patients: implications for precision medicine. Front Med 2021; 8: 650996. doi: 10.3389/fmed.2021.650996 XuG WangZ XiongZ LiM LuoW XuY Correlation between pulmonary sclerosing pneumocytoma features and MSCT imaging manifestations in 34 patients: implications for precision medicine Front Med 2021 8 650996 10.3389/fmed.2021.650996 Open DOISearch in Google Scholar

27. Cheung YC, Ng SH, Chang JW, Tan CF, Huang SF, Yu CT. Histopathological and CT features of pulmonary sclerosing haemangiomas. Clin Radiol 2003; 58: 630–5. doi: 10.1016/s0009-9260(03)00177-6 CheungYC NgSH ChangJW TanCF HuangSF YuCT Histopathological and CT features of pulmonary sclerosing haemangiomas Clin Radiol 2003 58 630 5 10.1016/s0009-9260(03)00177-6 Open DOISearch in Google Scholar

28. Chung MJ, Lee KS, Han J, Sung YM, Chong S, Kwon OJ. Pulmonary sclerosing hemangioma presenting as solitary pulmonary nodule: dynamic CT findings and histopathologic comparisons. Am J Roentgenol 2006; 187: 430–7. doi: 10.2214/AJR.05.0460 ChungMJ LeeKS HanJ SungYM ChongS KwonOJ Pulmonary sclerosing hemangioma presenting as solitary pulmonary nodule: dynamic CT findings and histopathologic comparisons Am J Roentgenol 2006 187 430 7 10.2214/AJR.05.0460 Open DOISearch in Google Scholar

29. Wang QB, Chen YQ, Shen JJ, Zhang C, Song B, Zhu XJ, et al. Sixteen cases of pulmonary sclerosing haemangioma: CT findings are not definitive for preoperative diagnosis. Clinical Radiology 2011; 66: 708–14. doi: 10.1016/j.crad.2011.03.002 WangQB ChenYQ ShenJJ ZhangC SongB ZhuXJ Sixteen cases of pulmonary sclerosing haemangioma: CT findings are not definitive for preoperative diagnosis Clinical Radiology 2011 66 708 14 10.1016/j.crad.2011.03.002 Open DOISearch in Google Scholar

30. Shin SY, Kim MY, Oh SY, Lee HJ, Hong SA, Jang SJ, et al. Pulmonary sclerosing pneumocytoma of the lung: CT characteristics in a large series of a tertiary referral center. Medicine (Baltimore) 2015; 94: 1–10. doi: 10.1097/MD.0000000000000498 ShinSY KimMY OhSY LeeHJ HongSA JangSJ Pulmonary sclerosing pneumocytoma of the lung: CT characteristics in a large series of a tertiary referral center Medicine (Baltimore) 2015 94 1 10 10.1097/MD.0000000000000498 Open DOISearch in Google Scholar

31. Trabucco SMR, Brascia D, Cazzato G, De Iaco G, Colagrande A, Signore F, et al. Pulmonary sclerosing pneumocytoma: a pre and intraoperative diagnostic challenge. Report of two cases and review of the literature. Medicina (Kaunas) 2021; 57: 524. doi: 10.3390/medicina57060524 TrabuccoSMR BrasciaD CazzatoG De IacoG ColagrandeA SignoreF Pulmonary sclerosing pneumocytoma: a pre and intraoperative diagnostic challenge. Report of two cases and review of the literature Medicina (Kaunas) 2021 57 524 10.3390/medicina57060524 Open DOISearch in Google Scholar

32. Bae K, Song DH, Jeon KN, Kim SH. Pulmonary sclerosing pneumocytoma presenting a peritumoral halo and an intervening lucent zone on computed tomography: radiology-pathology correlation. Thorac Cancer 2019; 10: 1295–6. doi: 10.1111/1759-7714.13069 BaeK SongDH JeonKN KimSH Pulmonary sclerosing pneumocytoma presenting a peritumoral halo and an intervening lucent zone on computed tomography: radiology-pathology correlation Thorac Cancer 2019 10 1295 6 10.1111/1759-7714.13069 Open DOISearch in Google Scholar